Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Recursion Pharmaceuticals, Inc. (RXRX)
USD3.34
0.00 (-0.06%)
US NASDAQ Healthcare Biotechnology
Address
41 South Rio Grande Street 84101
Salt Lake City, UT, US
Salt Lake City, UT, US
CEO
Najat Khan
Website
recursion.com
IPO
2021-04-16
CIK 1601830 ISIN US75629V1044
Description
Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase. The company's mission is to revolutionize drug discovery by decoding biological processes, utilizing an integrated approach that combines technological innovations across biology, chemistry, automation, data science, and engineering. Their developmental pipeline features several clinical-stage compounds: REC-994, which is advancing through Phase IIa trials for cerebral cavernous malformation; REC-3599, currently in Phase I trials for GM2 gangliosidosis; REC-2282, aimed at treating neurofibromatosis type 2; and REC-4881, intended for familial adenomatous polyposis. Beyond these, Recursion maintains a comprehensive preclinical portfolio. This includes REC-3964 for Clostridium difficile colitis, REC-64917 targeting neural or systemic inflammation, and REC-65029 for HRD-negative ovarian cancer. Further preclinical candidates are REC-648918, designed to enhance anti-tumor immunity; REC-2029 for wnt-mutant hepatocellular carcinoma; REC-14221 for various solid and hematological malignancies; and REC-64151, focused on addressing immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has established strategic collaborations and agreements with partners such as Bayer AG, the University of Utah Research Foundation, the Ohio State Innovation Foundation, Chromaderm, Inc., and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.
News Sentiment (7d)
4 articles
- 3 Cancer Stocks to Watch as Oncology Innovation Accelerates Zacks Investment Research
- Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought Fool - Investing News
- Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026? The Motley Fool
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD3.34
0.00 (-0.06%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
17M
Beta
1.00
Float Shares
348.36M
Free Float %
77.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.81% | -3.26% | -0.61% | -8.94% | -29.89% | -20.29% | -29.74% | -38.37% | -85.34% | -81.89% | -81.89% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Hold
Price Targets & DCF
Current price
3.34
Low
11.00
+229.5%
Consensus
11.00
+229.5%
Median
11.00
+229.5%
High
11.00
+229.5%
Ratings Trend (MoM)
38% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | 0 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 2 |
11.00
+229.5%
|
| All Time | 7 |
10.43
+212.5%
|
Quality scores
Altman Z-Score
-0.30
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+26.9% ★ Q1'26: -56.1% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+14.8% Q1'26: +56.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-741.6% Q1'26: -1,257.1% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-861.1% Q1'26: -1,985.6% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-138.1% Q1'26: -111.7% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+63.2% Q1'26: +31.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.14× Q1'26: -0.17× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 7 Rev. Ana. 6 EPS Ana. |
Dec 2028 3 Rev. Ana. 1 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.00M
est: 12.32M (-18.9%)
|
39.68M
est: 48.26M (-17.8%)
|
43.88M
est: 49.64M (-11.6%)
|
58.84M
est: 70.75M (-16.8%)
|
74.68M
est: 61.52M (+21.4%)
|
61.19M
18.37M – 94.53M
-0.5% YoY
|
111.44M
59.90M – 248.93M
+82.1% YoY
|
153.30M
63.24M – 327.49M
+37.6% YoY
|
247.50M
102.10M – 528.72M
+61.4% YoY
|
| EBITDA |
-175.12M
est: -12.32M (-1,320.9%)
|
-227.67M
est: -48.26M (-371.7%)
|
-307.63M
est: -49.64M (-519.8%)
|
-426.72M
est: -70.75M (-503.2%)
|
-559.38M
est: -61.52M (-809.3%)
|
-61.19M
-94.53M – -18.37M
+0.5% YoY
|
-111.44M
-248.93M – -59.90M
-82.1% YoY
|
-153.30M
-327.49M – -63.24M
-37.6% YoY
|
-247.50M
-528.72M – -102.10M
-61.4% YoY
|
| EBIT |
-183.53M
est: -12.32M (-1,389.1%)
|
-239.42M
est: -48.26M (-396.1%)
|
-332.03M
est: -49.64M (-568.9%)
|
-463.22M
est: -70.75M (-554.7%)
|
-643.09M
est: -61.52M (-945.3%)
|
-61.19M
-94.53M – -18.37M
+0.5% YoY
|
-111.44M
-248.93M – -59.90M
-82.1% YoY
|
-153.30M
-327.49M – -63.24M
-37.6% YoY
|
-247.50M
-528.72M – -102.10M
-61.4% YoY
|
| Net Income |
-186.48M
est: -326.31M (+42.9%)
|
-239.48M
est: -406.85M (+41.1%)
|
-328.07M
est: -374.93M (+12.5%)
|
-463.66M
est: -649.13M (+28.6%)
|
-644.76M
est: -696.59M (+7.4%)
|
-462.28M
-475.05M – -355.32M
+33.6% YoY
|
-465.91M
-527.89M – -263.94M
-0.8% YoY
|
-451.30M
-860.84M – -82.12M
+3.1% YoY
|
-420.60M
-1.04B – -99.39M
+6.8% YoY
|
| SGA |
57.68M
est: 51.22M (+12.6%)
|
81.60M
est: 200.57M (-59.3%)
|
110.82M
est: 156.28M (-29.1%)
|
178.18M
est: 222.76M (-20.0%)
|
176.59M
est: 193.71M (-8.8%)
|
192.68M
57.83M – 297.65M
-0.5% YoY
|
350.89M
188.60M – 783.79M
+82.1% YoY
|
482.69M
199.13M – 1.03B
+37.6% YoY
|
779.29M
321.49M – 1.66B
+61.4% YoY
|
| EPS |
-1.05
est: -1.19 (+11.8%)
|
-1.36
est: -1.41 (+3.3%)
|
-1.58
est: -1.64 (+3.9%)
|
-1.69
est: -1.54 (-9.8%)
|
-1.44
est: -1.57 (+8.1%)
|
-0.93
-1.06 – -0.79
+40.5% YoY
|
-0.88
-1.18 – -0.59
+5.6% YoY
|
-0.78
-1.92 – -0.18
+11.7% YoY
|
-0.94
-2.33 – -0.22
-21.0% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-30 | JP Morgan | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-304.44M
OE per share TTM
-0.67
Owner's Yield
-16.77%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
327.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
91
Total invested
31.67M
Insider transactions (90d)
1
Beneficial owners (>5%)
27
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management LLC | 20.65M | 9.92% | 19.87M | 469.2K | 20.65M | — | IA | Delaware, United States | 2024-01-29 | ↗ |
| 2 | Peter Kolchinsky | 15.38M | 5.90% | — | 15.38M | — | — | HC, IN | Delaware | 2024-07-08 | ↗ |
| 3 | RA Capital Healthcare Fund, L.P. | 15.38M | 5.90% | — | 15.38M | — | — | PN | Delaware | 2024-07-08 | ↗ |
| 4 | RA Capital Management, L.P. | 15.38M | 5.90% | — | 15.38M | — | — | IA, PN | Delaware | 2024-07-08 | ↗ |
| 5 | Rajeev Shah | 15.38M | 5.90% | — | 15.38M | — | — | HC, IN | Delaware | 2024-07-08 | ↗ |
| 6 | Matthew Ocko (“Ocko”) | 13.62M | 8.50% | — | 13.62M | — | 13.62M | IN | U.S. Citizen | 2022-02-14 | ↗ |
| 7 | Zachary Bogue (“Bogue”) | 13.62M | 8.50% | — | 13.62M | — | 13.62M | IN | U.S. Citizen | 2022-02-14 | ↗ |
| 8 | Josh Wolfe | 13.02M | 8.20% | — | 13.02M | — | — | IN | — | 2022-02-14 | ↗ |
| 9 | Lux Capital Management, LLC | 13.02M | 8.20% | — | 13.02M | — | — | OO | (4) Citizenship or Place of Organization | 2022-02-14 | ↗ |
| 10 | Peter Hebert | 13.02M | 8.20% | — | 13.02M | — | — | IN | (4) Citizenship or Place of Organization | 2022-02-14 | ↗ |
| 11 | STATE STREET CORPORATION | 12.15M | 5.83% | — | 11.84M | — | 12.15M | HC | BOSTON, MASSACHUSETTS | 2024-01-24 | ↗ |
| 12 | Abigail P. Johnson | 10.90M | 5.23% | — | — | 10.90M | — | IN | Delaware | 2024-02-09 | ↗ |
| 13 | FMR LLC | 10.90M | 5.23% | 10.89M | — | 10.90M | — | HC | Delaware | 2024-02-09 | ↗ |
| 14 | (1) BlackRock, Inc. | 10.67M | 5.90% | 10.39M | — | 10.67M | — | HC | Delaware | 2023-02-03 | ↗ |
| 15 | Invik S.A. | 10.41M | 5.60% | — | 10.41M | — | 10.41M | CO | Sweden | 2023-05-22 | ↗ |
| 16 | Kinnevik AB | 10.41M | 5.60% | — | 10.41M | — | 10.41M | CO | Sweden | 2023-05-22 | ↗ |
| 17 | The Vanguard Group - 23-1945930 | 10.06M | 5.54% | — | 89.2K | — | 183.9K | IA | — | 2023-02-09 | ↗ |
| 18 | Lux Venture Partners IV, LLC | 9.95M | 6.20% | — | 9.95M | — | — | OO | (4) Citizenship or Place of Organization | 2022-02-14 | ↗ |
| 19 | Lux Ventures IV, L.P. | 9.95M | 6.20% | — | 9.95M | — | — | PN | (4) Citizenship or Place of Organization | 2022-02-14 | ↗ |
| 20 | Data Collective IV GP, LLC (“DCVC IV GP”) | 5.94M | 3.70% | 5.94M | — | 5.94M | — | OO | Delaware | 2022-02-14 | ↗ |
| 21 | Data Collective IV, L.P. (“DCVC IV”) | 5.94M | 3.70% | 5.94M | — | 5.94M | — | PN | — | 2022-02-14 | ↗ |
| 22 | DCVC Opportunity Fund II GP, LLC (“DCVC OF II GP”) | 3.95M | 2.50% | 3.95M | — | 3.95M | — | OO | Delaware | 2022-02-14 | ↗ |
| 23 | DCVC Opportunity Fund II, L.P. (“DCVC OF II”) | 3.95M | 2.50% | 3.95M | — | 3.95M | — | PN | Delaware | 2022-02-14 | ↗ |
| 24 | DCVC V GP, LLC (“DCVC V GP”) | 3.73M | 2.30% | 3.73M | — | 3.73M | — | OO | Delaware | 2022-02-14 | ↗ |
| 25 | DCVC V, L.P. (“DCVC V”) | 3.73M | 2.30% | 3.73M | — | 3.73M | — | PN | — | 2022-02-14 | ↗ |
| 26 | Lux Co-Invest Opportunities, L.P. | 3.07M | 1.90% | — | 3.07M | — | — | PN | — | 2022-02-14 | ↗ |
| 27 | Lux Co-Invest Partners, LLC | 3.07M | 1.90% | — | 3.07M | — | — | OO | (4) Citizenship or Place of Organization | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
91
-254 vs prev Q
New positions
14
Closed positions
257
Increased
52
Reduced
16
Put/Call ratio
0.00
Calls held
1.2K
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 47.19M +7.4M (+18.6%) | 193.00M -1.1M (-0.6%) | 10.56% +1.026 pp | 0.00% 0.000 pp | USD8.71 -53.0% | 19 qtrs — |
| 2 | BLACKROCK, INC. | 38.87M +7.1M (+22.5%) | 158.97M +4.1M (+2.6%) | 8.70% +1.090 pp | 0.00% +0.000 pp | USD5.80 -29.5% | 6 qtrs — |
| 3 | ARK INVESTMENT MANAGEMENT LLC | 37.32M +3.8M (+11.2%) | 152.63M -11.1M (-6.8%) | 8.35% +0.311 pp | 1.01% +0.039 pp | USD9.30 -56.0% | 19 qtrs — |
| 4 | STATE STREET CORP | 25.33M +7.1M (+38.7%) | 103.62M +14.5M (+16.2%) | 5.67% +1.290 pp | 0.00% +0.000 pp | USD6.27 -34.8% | 19 qtrs — |
| 5 | BAILLIE GIFFORD & CO | 23.77M -203.7K (-0.8%) | 97.24M -19.8M (-16.9%) | 5.32% -0.426 pp | 0.08% -0.006 pp | USD28.35 -85.6% | 19 qtrs — |
| 6 | SOFTBANK GROUP CORP. | 13.64M -1.0M (-7.0%) | 55.77M -15.8M (-22.1%) | 3.05% -0.464 pp | 0.36% +0.085 pp | USD6.76 -39.5% | 5 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 10.93M +1.3M (+13.6%) | 44.73M -2.2M (-4.8%) | 2.45% +0.140 pp | 0.00% 0.000 pp | USD8.54 -52.1% | 19 qtrs — |
| 8 | MIC CAPITAL MANAGEMENT UK LLP | 9.64M +— (+0.0%) | 39.44M -7.6M (-16.2%) | 2.16% -0.153 pp | 8.94% -0.468 pp | USD9.26 -55.8% | 17 qtrs — |
| 9 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 6.22M -1.2M (-16.7%) | 25.44M -11.0M (-30.2%) | 1.39% -0.397 pp | 0.01% -0.006 pp | USD9.09 -55.0% | 19 qtrs — |
| 10 | NIKKO ASSET MANAGEMENT AMERICAS, INC. | 6.22M -1.2M (-16.7%) | 25.38M -11.0M (-30.2%) | 1.39% -0.397 pp | 0.29% -0.059 pp | USD9.80 -58.3% | 19 qtrs — |
| 11 | DATA COLLECTIVE IV GP, LLC | 5.94M +— (+0.0%) | 24.30M -4.7M (-16.2%) | 1.33% -0.094 pp | 41.53% -1.114 pp | USD17.13 -76.1% | 17 qtrs — |
| 12 | NORGES BANK | 5.74M +5.7M (+100.0%) | 23.47M +23.5M (+100.0%) | 1.28% +1.284 pp | 0.00% +0.003 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 13 | MORGAN STANLEY | 5.66M -1.6M (-22.4%) | 23.14M -12.4M (-35.0%) | 1.27% -0.481 pp | 0.00% -0.001 pp | USD6.43 -36.4% | 19 qtrs — |
| 14 | EXOR CAPITAL LLP | 4.93M +1.3M (+34.2%) | 20.17M +2.2M (+12.5%) | 1.10% +0.223 pp | 0.35% +0.020 pp | USD7.25 -43.6% | 11 qtrs — |
| 15 | UBS ASSET MANAGEMENT AMERICAS INC | 4.08M -121.8K (-2.9%) | 16.67M -3.8M (-18.6%) | 0.91% -0.094 pp | 0.00% -0.001 pp | USD6.10 -33.0% | 17 qtrs — |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.99M +549.6K (+16.0%) | 16.34M -473.6K (-2.8%) | 0.89% +0.068 pp | 0.00% 0.000 pp | USD8.28 -50.6% | 19 qtrs — |
| 17 | DCVC OPPORTUNITY FUND II GP, LLC | 3.95M +— (+0.0%) | 16.16M -3.1M (-16.2%) | 0.88% -0.063 pp | 97.42% -2.576 pp | USD9.86 -58.5% | 9 qtrs — |
| 18 | UBS GROUP AG | 3.69M -61.8K (-1.6%) | 15.10M -3.2M (-17.6%) | 0.83% -0.073 pp | 0.00% 0.000 pp | USD6.26 -34.7% | 19 qtrs — |
| 19 | NORTHERN TRUST CORP | 3.44M +102.7K (+3.1%) | 14.07M -2.2M (-13.6%) | 0.77% -0.030 pp | 0.00% 0.000 pp | USD10.27 -60.2% | 19 qtrs — |
| 20 | FMR LLC | 3.24M +13.0K (+0.4%) | 13.26M -2.5M (-15.9%) | 0.73% -0.048 pp | 0.00% 0.000 pp | USD11.79 -65.3% | 19 qtrs — |
| 21 | TWO SIGMA INVESTMENTS, LP | 3.08M +624.3K (+25.5%) | 12.58M +617.3K (+5.2%) | 0.69% +0.101 pp | 0.02% 0.000 pp | USD5.89 -30.6% | 13 qtrs — |
| 22 | IQ EQ FUND MANAGEMENT (IRELAND) LTD | 2.40M +629.1K (+35.4%) | 9.83M +1.2M (+13.5%) | 0.54% +0.113 pp | 0.68% +0.091 pp | USD4.91 -16.7% | 7 qtrs — |
| 23 | FIRST TRUST ADVISORS LP | 2.27M +469.5K (+26.1%) | 9.27M +500.4K (+5.7%) | 0.51% +0.077 pp | 0.01% +0.000 pp | USD4.96 -17.5% | 4 qtrs — |
| 24 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.21M +173.5K (+8.5%) | 9.03M -897.4K (-9.0%) | 0.49% +0.007 pp | 0.00% 0.000 pp | USD5.83 -29.8% | 15 qtrs — |
| 25 | GOLDMAN SACHS GROUP INC | 2.20M +939.8K (+74.5%) | 9.00M +2.8M (+46.2%) | 0.49% +0.190 pp | 0.00% +0.000 pp | USD6.24 -34.5% | 19 qtrs — |
| 26 | BANK OF AMERICA CORP /DE/ | 2.11M +888.4K (+72.6%) | 8.64M +2.7M (+44.6%) | 0.47% +0.179 pp | 0.00% +0.000 pp | USD6.04 -32.3% | 19 qtrs — |
| 27 | CITADEL ADVISORS LLC | 1.98M +35.7K (+1.8%) | 8.09M -1.4M (-14.6%) | 0.44% -0.023 pp | 0.00% 0.000 pp | USD5.59 -26.8% | 19 qtrs — |
| 28 | CAPITAL FUND MANAGEMENT S.A. | 1.78M +1.1M (+145.0%) | 7.28M +3.7M (+105.4%) | 0.40% +0.224 pp | 0.02% +0.011 pp | USD4.66 -12.2% | 5 qtrs — |
| 29 | PEAK6 LLC | 1.63M +396.0K (+32.0%) | 6.67M +643.2K (+10.7%) | 0.37% +0.069 pp | 0.01% +0.004 pp | USD4.83 -15.3% | 4 qtrs — |
| 30 | MILLENNIUM MANAGEMENT LLC | 1.50M +1.5M (+100.0%) | 6.12M +6.1M (+100.0%) | 0.33% +0.335 pp | 0.00% +0.003 pp | USD4.09 +0.0% | 17 qtrs — |
| 31 | BARCLAYS PLC | 1.47M +771.8K (+110.7%) | 6.01M +1.4M (+30.7%) | 0.33% +0.162 pp | 0.00% +0.000 pp | USD5.11 -20.0% | 16 qtrs — |
| 32 | JPMORGAN CHASE & CO | 1.28M +859.3K (+204.8%) | 5.23M +3.2M (+155.4%) | 0.29% +0.186 pp | 0.00% +0.000 pp | USD5.66 -27.7% | 19 qtrs — |
| 33 | WELLS FARGO & COMPANY/MN | 1.16M +359.6K (+44.9%) | 4.75M +837.8K (+21.4%) | 0.26% +0.068 pp | 0.00% +0.000 pp | USD4.94 -17.2% | 17 qtrs — |
| 34 | BANK OF NEW YORK MELLON CORP | 1.13M -238.1K (-17.4%) | 4.63M -2.1M (-30.8%) | 0.25% -0.075 pp | 0.00% -0.001 pp | USD10.07 -59.4% | 19 qtrs — |
| 35 | NUVEEN, LLC | 1.08M -191.5K (-15.0%) | 4.44M -1.8M (-28.8%) | 0.24% -0.063 pp | 0.00% -0.001 pp | USD5.27 -22.4% | 4 qtrs — |
| 36 | BNP PARIBAS ARBITRAGE, SNC | 1.08M +971.1K (+858.4%) | 4.43M +3.9M (+703.3%) | 0.24% +0.216 pp | 0.00% +0.002 pp | USD4.22 -3.1% | 5 qtrs — |
| 37 | RAFFERTY ASSET MANAGEMENT, LLC | 968.8K +218.6K (+29.1%) | 3.96M +301.5K (+8.2%) | 0.22% +0.037 pp | 0.01% +0.002 pp | USD5.73 -28.6% | 18 qtrs — |
| 38 | COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 941.9K +— (+0.0%) | 3.85M -744.1K (-16.2%) | 0.21% -0.015 pp | 0.12% -0.011 pp | USD36.50 -88.8% | 19 qtrs — |
| 39 | SQUAREPOINT OPS LLC | 887.0K +887.0K (+100.0%) | 3.63M +3.6M (+100.0%) | 0.20% +0.198 pp | 0.00% +0.004 pp | USD4.09 +0.0% | 5 qtrs — |
| 40 | NATIONAL BANK OF CANADA /FI/ | 875.6K +870.5K (+17,101.8%) | 3.58M +3.6M (+14,324.7%) | 0.20% +0.195 pp | 0.00% +0.003 pp | USD4.10 -0.2% | 12 qtrs — |
| 41 | HSBC HOLDINGS PLC | 818.3K +689.9K (+537.3%) | 3.37M +2.8M (+448.6%) | 0.18% +0.152 pp | 0.00% +0.001 pp | USD4.28 -4.4% | 8 qtrs — |
| 42 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 799.1K +796.1K (+26,959.9%) | 3.27M +3.3M (+23,250.0%) | 0.18% +0.178 pp | 0.00% +0.004 pp | USD4.09 +0.0% | 3 qtrs — |
| 43 | DIADEMA PARTNERS LP | 741.9K +43.5K (+6.2%) | 3.03M -373.8K (-11.0%) | 0.17% -0.001 pp | 0.52% -0.349 pp | USD5.81 -29.6% | 5 qtrs — |
| 44 | SWISS NATIONAL BANK | 720.3K +99.7K (+16.1%) | 2.95M -82.5K (-2.7%) | 0.16% +0.012 pp | 0.00% +0.000 pp | USD7.64 -46.5% | 17 qtrs — |
| 45 | JANE STREET GROUP, LLC | 701.3K +621.8K (+782.1%) | 2.87M +2.5M (+639.3%) | 0.16% +0.138 pp | 0.00% +0.000 pp | USD4.33 -5.5% | 6 qtrs — |
| 46 | BALYASNY ASSET MANAGEMENT L.P. | 668.2K +105.7K (+18.8%) | 2.73M -11.9K (-0.4%) | 0.15% +0.015 pp | 0.00% +0.000 pp | USD4.75 -13.9% | 4 qtrs — |
| 47 | ALGERT GLOBAL LLC | 664.5K +664.5K (+100.0%) | 2.72M +2.7M (+100.0%) | 0.15% +0.149 pp | 0.04% +0.042 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 48 | JUMP FINANCIAL, LLC | 661.6K +106.6K (+19.2%) | 2.71M -2.7K (-0.1%) | 0.15% +0.015 pp | 0.03% +0.001 pp | USD5.02 -18.5% | 5 qtrs — |
| 49 | POINT72 ASSET MANAGEMENT, L.P. | 654.2K +654.2K (+100.0%) | 2.68M +2.7M (+100.0%) | 0.15% +0.146 pp | 0.00% +0.003 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 50 | VESTMARK ADVISORY SOLUTIONS, INC. | 604.8K -16.3K (-2.6%) | 2.47M -557.3K (-18.4%) | 0.14% -0.014 pp | 0.03% -0.024 pp | USD7.27 -43.7% | 9 qtrs — |
| 51 | PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 595.5K +— (+0.0%) | 2.44M -470.5K (-16.2%) | 0.13% -0.010 pp | 0.94% -0.738 pp | USD6.76 -39.5% | 5 qtrs — |
| 52 | NAN FUNG GROUP HOLDINGS LTD | 595.3K +— (+0.0%) | 2.43M -470.3K (-16.2%) | 0.13% -0.010 pp | 2.18% -2.694 pp | USD6.76 -39.5% | 5 qtrs — |
| 53 | STIFEL FINANCIAL CORP | 590.1K +147.4K (+33.3%) | 2.41M +252.9K (+11.7%) | 0.13% +0.026 pp | 0.00% +0.000 pp | USD5.51 -25.8% | 9 qtrs — |
| 54 | INVESCO LTD. | 526.1K +108.0K (+25.8%) | 2.15M +111.3K (+5.5%) | 0.12% +0.018 pp | 0.00% +0.000 pp | USD6.10 -33.0% | 19 qtrs — |
| 55 | RHUMBLINE ADVISERS | 507.2K -13.6K (-2.6%) | 2.07M -466.9K (-18.4%) | 0.11% -0.011 pp | 0.00% 0.000 pp | USD9.28 -55.9% | 19 qtrs — |
| 56 | LPL FINANCIAL LLC | 433.1K +34.1K (+8.5%) | 1.77M -175.8K (-9.0%) | 0.10% +0.001 pp | 0.00% 0.000 pp | USD7.27 -43.7% | 15 qtrs — |
| 57 | HUDSON BAY CAPITAL MANAGEMENT LP | 425.0K +200.0K (+88.9%) | 1.74M +640.3K (+58.3%) | 0.10% +0.041 pp | 0.01% +0.002 pp | USD5.03 -18.7% | 11 qtrs — |
| 58 | LAZARD ASSET MANAGEMENT LLC | 420.0K -75.2K (-15.2%) | 1.72M -698.6K (-28.9%) | 0.09% -0.025 pp | 0.00% 0.000 pp | USD7.55 -45.8% | 17 qtrs — |
| 59 | PRICE T ROWE ASSOCIATES INC /MD/ | 415.4K +96.5K (+30.3%) | 1.70M +142.0K (+9.1%) | 0.09% +0.017 pp | 0.00% +0.000 pp | USD6.53 -37.4% | 19 qtrs — |
| 60 | VERITION FUND MANAGEMENT LLC | 412.7K +358.2K (+656.3%) | 1.69M +1.4M (+533.8%) | 0.09% +0.079 pp | 0.01% +0.006 pp | USD4.23 -3.3% | 4 qtrs — |
| 61 | CARROLL INVESTORS, INC | 404.9K +8.2K (+2.1%) | 1.66M -279.7K (-14.4%) | 0.09% -0.005 pp | 0.79% -0.146 pp | USD6.30 -35.1% | 8 qtrs — |
| 62 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 396.3K +187.5K (+89.8%) | 1.62M +602.0K (+59.0%) | 0.09% +0.039 pp | 0.00% +0.001 pp | USD5.43 -24.7% | 7 qtrs — |
| 63 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 391.8K +186.6K (+90.9%) | 1.60M +600.9K (+60.0%) | 0.09% +0.039 pp | 0.01% +0.002 pp | USD4.52 -9.5% | 3 qtrs — |
| 64 | SCULPTOR CAPITAL LP | 386.0K +— (+0.0%) | 1.58M -304.9K (-16.2%) | 0.09% -0.006 pp | 0.02% -0.006 pp | USD5.06 -19.2% | 3 qtrs — |
| 65 | LEGAL & GENERAL GROUP PLC | 364.7K +11.1K (+3.1%) | 1.49M -234.0K (-13.6%) | 0.08% -0.003 pp | 0.00% 0.000 pp | USD7.25 -43.6% | 19 qtrs — |
| 66 | ALLIANCEBERNSTEIN L.P. | 361.4K -508.0 (-0.1%) | 1.48M -288.0K (-16.3%) | 0.08% -0.006 pp | 0.00% 0.000 pp | USD11.55 -64.6% | 19 qtrs — |
| 67 | PROFUND ADVISORS LLC | 356.7K +195.2K (+120.9%) | 1.46M +670.8K (+85.1%) | 0.08% +0.041 pp | 0.04% +0.019 pp | USD4.88 -16.2% | 12 qtrs — |
| 68 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 350.3K +18.1K (+5.4%) | 1.43M -188.4K (-11.6%) | 0.08% -0.001 pp | 0.00% 0.000 pp | USD9.26 -55.8% | 19 qtrs — |
| 69 | TWO SIGMA ADVISERS, LP | 313.9K -501.5K (-61.5%) | 1.28M -2.7M (-67.7%) | 0.07% -0.125 pp | 0.00% -0.006 pp | USD4.88 -16.2% | 9 qtrs — |
| 70 | DEUTSCHE BANK AG\ | 297.5K +27.9K (+10.4%) | 1.22M -98.7K (-7.5%) | 0.07% +0.002 pp | 0.00% +0.000 pp | USD7.95 -48.6% | 19 qtrs — |
| 71 | SHAY CAPITAL LLC | 279.8K +231.5K (+479.2%) | 1.14M +908.8K (+385.5%) | 0.06% +0.051 pp | 0.12% +0.098 pp | USD4.23 -3.3% | 2 qtrs — |
| 72 | HRT FINANCIAL LP | 256.6K +256.6K (+100.0%) | 1.05M +1.0M (+100.0%) | 0.06% +0.057 pp | 0.00% +0.003 pp | USD4.09 +0.0% | 3 qtrs — |
| 73 | AMERICAN CENTURY COMPANIES INC | 242.0K -74.2K (-23.5%) | 989.6K -553.3K (-35.9%) | 0.05% -0.022 pp | 0.00% 0.000 pp | USD4.88 -16.2% | 2 qtrs — |
| 74 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 232.4K +2.8K (+1.2%) | 954.4K -166.1K (-14.8%) | 0.05% -0.003 pp | 0.00% 0.000 pp | USD4.87 -16.0% | 4 qtrs — |
| 75 | HEADLANDS TECHNOLOGIES LLC | 231.5K +42.4K (+22.4%) | 946.7K +23.8K (+2.6%) | 0.05% +0.007 pp | 0.08% +0.005 pp | USD5.64 -27.5% | 7 qtrs — |
| 76 | MARSHALL WACE, LLP | 226.6K +148.4K (+189.6%) | 926.8K +544.9K (+142.7%) | 0.05% +0.032 pp | 0.00% +0.001 pp | USD4.50 -9.1% | 4 qtrs — |
| 77 | SBI SECURITIES CO., LTD. | 223.9K +95.8K (+74.8%) | 915.8K +290.7K (+46.5%) | 0.05% +0.019 pp | 0.02% +0.008 pp | USD5.02 -18.5% | 5 qtrs — |
| 78 | ALLEN OPERATIONS LLC | 217.7K +— (+0.0%) | 890.2K -171.9K (-16.2%) | 0.05% -0.004 pp | 0.11% -0.015 pp | USD23.19 -82.4% | 19 qtrs — |
| 79 | METLIFE INVESTMENT MANAGEMENT, LLC | 209.8K -5.4K (-2.5%) | 858.1K -192.3K (-18.3%) | 0.05% -0.005 pp | 0.00% -0.001 pp | USD9.25 -55.8% | 19 qtrs — |
| 80 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 204.9K +18.4K (+9.9%) | 838.2K -72.1K (-7.9%) | 0.05% +0.001 pp | 0.00% 0.000 pp | USD9.06 -54.9% | 19 qtrs — |
| 81 | GUGGENHEIM CAPITAL LLC | 183.4K +57.5K (+45.6%) | 750.3K +135.4K (+22.0%) | 0.04% +0.011 pp | 0.01% +0.001 pp | USD6.23 -34.3% | 11 qtrs — |
| 82 | CITIGROUP INC | 170.3K +103.9K (+156.5%) | 696.5K +372.4K (+114.9%) | 0.04% +0.022 pp | 0.00% +0.000 pp | USD5.09 -19.6% | 19 qtrs — |
| 83 | STATE OF WISCONSIN INVESTMENT BOARD | 167.9K -10.5K (-5.9%) | 686.6K -183.7K (-21.1%) | 0.04% -0.005 pp | 0.00% -0.001 pp | USD9.02 -54.7% | 19 qtrs — |
| 84 | CASDIN CAPITAL, LLC | 165.3K +— (+0.0%) | 676.2K -130.6K (-16.2%) | 0.04% -0.003 pp | 0.04% -0.025 pp | USD6.76 -39.5% | 5 qtrs — |
| 85 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 159.5K +45.9K (+40.4%) | 652.6K +97.9K (+17.7%) | 0.04% +0.009 pp | 0.00% +0.000 pp | USD5.88 -30.4% | 18 qtrs — |
| 86 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 159.0K -28.9K (-15.4%) | 650.0K -268.0K (-29.2%) | 0.04% -0.010 pp | 0.00% -0.002 pp | USD10.37 -60.6% | 14 qtrs — |
| 87 | INTECH INVESTMENT MANAGEMENT LLC | 155.3K -3.9K (-2.5%) | 635.3K -141.8K (-18.3%) | 0.03% -0.003 pp | 0.01% -0.001 pp | USD5.90 -30.7% | 6 qtrs — |
| 88 | WELLINGTON MANAGEMENT GROUP LLP | 152.6K -661.0 (-0.4%) | 624.2K -123.8K (-16.5%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD5.95 -31.3% | 6 qtrs — |
| 89 | GREEN ALPHA ADVISORS, LLC | 151.1K -61.1K (-28.8%) | 617.9K -417.6K (-40.3%) | 0.03% -0.017 pp | 0.57% -0.434 pp | USD6.26 -34.7% | 10 qtrs — |
| 90 | RAIFFEISEN BANK INTERNATIONAL AG | 150.0K +10.0K (+7.1%) | 616.5K -70.9K (-10.3%) | 0.03% +0.000 pp | 0.01% -0.001 pp | USD6.46 -36.7% | 5 qtrs — |
| 91 | BENJAMIN EDWARDS INC | 146.8K +3.6K (+2.5%) | 600.3K -98.3K (-14.1%) | 0.03% -0.002 pp | 0.01% -0.001 pp | USD6.46 -36.7% | 9 qtrs — |
| 92 | MARATHON CAPITAL MANAGEMENT | 144.6K +4.6K (+3.3%) | 591.4K -91.8K (-13.4%) | 0.03% -0.001 pp | 0.13% -0.029 pp | USD7.51 -45.5% | 10 qtrs — |
| 93 | QUADRATURE CAPITAL LTD | 142.7K -53.2K (-27.2%) | 583.5K -371.5K (-38.9%) | 0.03% -0.015 pp | 0.01% -0.005 pp | USD5.04 -18.8% | 3 qtrs — |
| 94 | JANUS HENDERSON GROUP PLC | 138.2K +— (+0.0%) | 564.6K -109.2K (-16.2%) | 0.03% -0.002 pp | 0.00% 0.000 pp | USD6.40 -36.1% | 12 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 109 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ARK Genomic Revolution ETF ARKG | 2.94% | 38.37M | 0.75% |
| 2 | Global X HealthTech ETF HEAL | 1.61% | 480.6K | 0.50% |
| 3 | First Trust Nasdaq Artificial Intelligence and Robotics ETF ROBT | 1.49% | 10.91M | 0.65% |
| 4 | ARK Innovation ETF ARKK | 1.19% | 77.62M | 0.75% |
| 5 | WisdomTree Artificial Intelligence UCITS ETF - USD Acc WTAI.L | 0.89% | 13.15M | 0.40% |
| 6 | Themes Generative Artificial Intelligence ETF WISE | 0.77% | 225.6K | 0.35% |
| 7 | Global X - S&P Biotech ETF CURE.AX | 0.73% | 262.3K | 0.45% |
| 8 | State Street SPDR S&P Biotech ETF XBI | 0.73% | 79.02M | 0.35% |
| 9 | Virtus Biotech Clinical Trials ETF BBC | 0.70% | 400.4K | 0.65% |
| 10 | AXS Green Alpha ETF NXTE | 0.67% | 384.4K | 1.00% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.67
Neutral
Ratio by volume
0.37
Bearish
Buys
4
Sells
6
Shares acquired
88.2K
Shares disposed
238.0K
Cash buys
—
Cash sales
3.00
Net activity
-149,858
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 | Gibson Christopher | Director | C-Conversion | D | Class B Common Stock | 40,000 | 0.00 | — | 4,403,334 | D | ↗ |
| 2026-04-07 | Gibson Christopher | Director | C-Conversion | A | Class A Common Stock | 40,000 | 0.00 | — | 946,556 | D | ↗ |
| 2026-04-07 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 30,000 | 3.10 | 93.0K | 6,229,863 | D | ↗ |
| 2026-04-06 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 48,028 | 3.11 | 149.4K | 1,132,290 | D | ↗ |
| 2026-04-01 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 3,268 | 0.00 | — | 1,244,177 | D | ↗ |
| 2026-04-01 | Dar Zavain | Director | A-Award | A | Class A Common Stock | 4,902 | 0.00 | — | 147,231 | D | ↗ |
| 2026-03-23 | Gibson Christopher | Director | C-Conversion | D | Class B Common Stock | 40,000 | 0.00 | — | 4,483,334 | D | ↗ |
| 2026-03-17 | Taylor Ben R | Officer | S-Sale | D | Class A Common Stock | 7,956 | 3.39 | 27.0K | 1,180,318 | D | ↗ |
| 2026-03-16 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 7,075 | 3.42 | 24.2K | 1,188,274 | D | ↗ |
| 2026-03-09 | Khan Najat | Director / Officer | S-Sale | D | Class A Common Stock | 28,298 | 3.35 | 94.7K | 2,262,085 | D | ↗ |
| 2026-03-09 | Gibson Christopher | Director | G-Gift | D | Class A Common Stock | 20,000 | 0.00 | — | 906,556 | D | ↗ |
| 2026-03-03 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 170,000 | 3.46 | 588.2K | 6,259,863 | D | ↗ |
| 2026-02-19 | Gibson Christopher | Director | C-Conversion | D | Class B Common Stock | 40,000 | 0.00 | — | 4,543,334 | D | ↗ |
| 2026-02-18 | Taylor Ben R | Officer | S-Sale | D | Class A Common Stock | 13,426 | 3.08 | 41.4K | 1,195,349 | D | ↗ |
| 2026-02-17 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 11,908 | 3.49 | 41.6K | 1,208,775 | D | ↗ |
| 2026-02-17 | Khan Najat | Director / Officer | F-InKind | D | Class A Common Stock | 14,280 | 3.49 | 49.8K | 2,290,383 | D | ↗ |
| 2026-02-17 | Hallett David | Officer | F-InKind | D | Class A Common Stock | 11,908 | 3.49 | 41.6K | 1,097,151 | D | ↗ |
| 2026-02-17 | Gibson Christopher | Director | F-InKind | D | Class A Common Stock | 27,265 | 3.49 | 95.2K | 906,556 | D | ↗ |
| 2026-02-06 | Taylor Ben R | Officer | A-Award | A | Class A Common Stock | 446,279 | 0.00 | — | 1,207,829 | D | ↗ |
| 2026-02-06 | Khan Najat | Director / Officer | A-Award | A | Class A Common Stock | 1,673,546 | 0.00 | — | 2,284,681 | D | ↗ |
| 2026-02-06 | Hallett David | Officer | A-Award | A | Class A Common Stock | 502,064 | 0.00 | — | 1,096,205 | D | ↗ |
| 2026-02-06 | Gibson Christopher | Director | F-InKind | D | Class A Common Stock | 10,364 | 3.56 | 36.9K | 933,821 | D | ↗ |
| 2026-02-04 | Gibson Christopher | Director | C-Conversion | D | Class B Common Stock | 40,000 | 0.00 | — | 4,583,334 | D | ↗ |
| 2026-02-03 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 220,000 | 4.20 | 924.0K | 6,429,863 | D | ↗ |
| 2026-01-20 | Gibson Christopher | Director | C-Conversion | D | Class B Common Stock | 40,000 | 0.00 | — | 4,623,334 | D | ↗ |
| 2026-01-06 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 220,000 | 4.36 | 959.2K | 6,649,863 | D | ↗ |
| 2026-01-05 | Gibson Christopher | Director | S-Sale | D | Class A Common Stock | 40,000 | 4.25 | 170.0K | 933,839 | D | ↗ |
| 2026-01-02 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 2,381 | 0.00 | — | 1,240,909 | D | ↗ |
| 2026-01-02 | Dar Zavain | Director | A-Award | A | Class A Common Stock | 3,571 | 0.00 | — | 142,329 | D | ↗ |
| 2026-01-01 | Hallett David | Officer | — | — | Stock Option (Right to Buy) | 740,686 | 6.09 | 4.51M | 0 | D | ↗ |
| 2025-12-29 | Taylor Ben R | Officer | S-Sale | D | Class A Common Stock | 21,383 | 4.18 | 89.4K | 761,550 | D | ↗ |
| 2025-12-22 | Khan Najat | Director / Officer | S-Sale | D | Class A Common Stock | 124,403 | 4.41 | 548.6K | 611,135 | D | ↗ |
| 2025-12-19 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 40,000 | 0.00 | — | 4,723,334 | D | ↗ |
| 2025-12-15 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 7,057 | 4.33 | 30.6K | 782,933 | D | ↗ |
| 2025-12-04 | Gibson Christopher | Director / Officer | S-Sale | D | Class A Common Stock | 40,000 | 4.63 | 185.2K | 933,839 | D | ↗ |
| 2025-12-02 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 220,000 | 4.37 | 961.4K | 6,869,863 | D | ↗ |
| 2025-11-25 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 2,271 | 4.03 | 9.2K | 789,990 | D | ↗ |
| 2025-11-19 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 40,000 | 0.00 | — | 4,823,334 | D | ↗ |
| 2025-11-17 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 11,908 | 4.14 | 49.3K | 792,261 | D | ↗ |
| 2025-11-17 | Khan Najat | Director / Officer | F-InKind | D | Class A Common Stock | 17,584 | 4.14 | 72.8K | 735,538 | D | ↗ |
| 2025-11-17 | Gibson Christopher | Director / Officer | F-InKind | D | Class A Common Stock | 40,390 | 4.14 | 167.2K | 913,839 | D | ↗ |
| 2025-11-05 | Khan Najat | Director / Officer | A-Award | A | Class A Common Stock | 84,925 | 0.00 | — | 753,122 | D | ↗ |
| 2025-11-04 | Gibson Christopher | Director / Officer | C-Conversion | A | Class A Common Stock | 60,000 | 0.00 | — | 1,014,229 | D | ↗ |
| 2025-10-23 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 100,000 | 0.00 | — | 4,923,334 | D | ↗ |
| 2025-10-10 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 120,000 | 0.00 | — | 5,133,034 | D | ↗ |
| 2025-10-01 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 1,961 | 0.00 | — | 1,238,528 | D | ↗ |
| 2025-10-01 | Dar Zavain | Director | A-Award | A | Class A Common Stock | 2,941 | 0.00 | — | 138,758 | D | ↗ |
| 2025-09-25 | Gibson Christopher | Director / Officer | C-Conversion | A | Class A Common Stock | 100,000 | 0.00 | — | 1,054,229 | D | ↗ |
| 2025-09-15 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 7,057 | 4.83 | 34.1K | 804,169 | D | ↗ |
| 2025-09-10 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 120,000 | 0.00 | — | 5,253,034 | D | ↗ |
| 2025-08-26 | Gibson Christopher | Director / Officer | C-Conversion | A | Class A Common Stock | 100,000 | 0.00 | — | 1,054,229 | D | ↗ |
| 2025-08-18 | Khan Najat | Director / Officer | S-Sale | D | Class A Common Stock | 36,599 | 5.52 | 202.2K | 668,197 | D | ↗ |
| 2025-08-15 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 11,908 | 5.64 | 67.2K | 811,226 | D | ↗ |
| 2025-08-15 | Khan Najat | Director / Officer | F-InKind | D | Class A Common Stock | 3,789 | 5.64 | 21.4K | 704,796 | D | ↗ |
| 2025-08-15 | Gibson Christopher | Director / Officer | F-InKind | D | Class A Common Stock | 40,390 | 5.64 | 227.8K | 954,229 | D | ↗ |
| 2025-08-11 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 423,666 | 0.00 | — | 5,473,034 | D | ↗ |
| 2025-07-01 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 1,949 | 0.00 | — | 1,236,567 | D | ↗ |
| 2025-07-01 | Dar Zavain | Director | A-Award | A | Class A Common Stock | 2,924 | 0.00 | — | 135,817 | D | ↗ |
| 2025-06-18 | Sun Elaine D | Director | A-Award | A | Class A Common Stock | 11,008 | 0.00 | — | 47,557 | D | ↗ |
| 2025-06-18 | Michor Franziska | Director | A-Award | A | Class A Common Stock | 22,016 | 0.00 | — | 127,053 | D | ↗ |
| 2025-06-18 | Li Dean Y | Director | A-Award | A | Stock Option (Right to Buy) | 44,031 | 5.11 | 225.0K | 44,031 | D | ↗ |
| 2025-06-18 | HERSHBERG ROBERT | Director | A-Award | A | Class A Common Stock | 22,016 | 0.00 | — | 73,732 | D | ↗ |
| 2025-06-18 | Dar Zavain | Director | A-Award | A | Stock Option (Right to Buy) | 44,031 | 5.11 | 225.0K | 44,031 | D | ↗ |
| 2025-06-18 | Bumpus Namandje | Director | A-Award | A | Stock Option (Right to Buy) | 22,016 | 5.11 | 112.5K | 22,016 | D | ↗ |
| 2025-06-18 | Borgeson Blake | Director | A-Award | A | Stock Option (Right to Buy) | 44,031 | 5.11 | 225.0K | 44,031 | D | ↗ |
| 2025-06-16 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 7,057 | 4.92 | 34.7K | 823,134 | D | ↗ |
| 2025-05-15 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 11,908 | 4.25 | 50.6K | 830,191 | D | ↗ |
| 2025-05-15 | Khan Najat | Director / Officer | F-InKind | D | Class A Common Stock | 3,796 | 4.25 | 16.1K | 708,585 | D | ↗ |
| 2025-05-15 | Gibson Christopher | Director / Officer | F-InKind | D | Class A Common Stock | 36,197 | 4.25 | 153.8K | 1,081,253 | D | ↗ |
| 2025-04-01 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 26,571 | 5.10 | 135.4K | 842,099 | D | ↗ |
| 2025-04-01 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 2,268 | 0.00 | — | 79,618 | D | ↗ |
| 2025-04-01 | Dar Zavain | Director | A-Award | A | Class A Common Stock | 2,745 | 0.00 | — | 110,877 | D | ↗ |
| 2025-03-27 | Gibson Christopher | Director / Officer | S-Sale | D | Class A Common Stock | 138,574 | 6.04 | 837.0K | 1,117,450 | D | ↗ |
| 2025-03-17 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 7,057 | 6.84 | 48.3K | 868,670 | D | ↗ |
| 2025-03-17 | Sun Elaine D | Director | A-Award | A | Class A Common Stock | 36,549 | 0.00 | — | 36,549 | D | ↗ |
| 2025-03-17 | Bumpus Namandje | Director | A-Award | A | Class A Common Stock | 36,549 | 0.00 | — | 36,549 | D | ↗ |
| 2025-03-15 | Sun Elaine D | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-15 | Bumpus Namandje | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-06 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 5,896,700 | D | ↗ |
| 2025-03-05 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 5,916,700 | D | ↗ |
| 2025-02-18 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 10,879 | 10.64 | 115.8K | 875,727 | D | ↗ |
| 2025-02-18 | Gibson Christopher | Director / Officer | F-InKind | D | Class A Common Stock | 17,132 | 10.64 | 182.3K | 1,256,024 | D | ↗ |
| 2025-02-06 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 5,936,700 | D | ↗ |
| 2025-02-05 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 5,956,700 | D | ↗ |
| 2025-02-03 | Taylor Ben R | Officer | A-Award | A | Class A Common Stock | 35,018 | 0.00 | — | 879,228 | D | ↗ |
| 2025-02-03 | Khan Najat | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 420,226 | 7.25 | 3.05M | 420,226 | D | ↗ |
| 2025-02-03 | Gibson Christopher | Director / Officer | A-Award | A | Class A Common Stock | 16,809 | 0.00 | — | 1,278,725 | D | ↗ |
| 2025-01-10 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 5,976,700 | D | ↗ |
| 2025-01-08 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 5,996,700 | D | ↗ |
| 2025-01-02 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 1,647 | 0.00 | — | 77,350 | D | ↗ |
| 2025-01-02 | Dar Zavain | Director | A-Award | A | Class A Common Stock | 1,907 | 0.00 | — | 108,132 | D | ↗ |
| 2025-01-02 | Borgeson Blake | Director | A-Award | A | Class A Common Stock | 1,734 | 0.00 | — | 7,067,847 | D | ↗ |
| 2024-12-19 | Taylor Ben R | Officer | A-Award | A | Class A Common Stock | 370,343 | 0.00 | — | 844,210 | D | ↗ |
| 2024-12-17 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 7,057 | 6.95 | 49.0K | 473,867 | D | ↗ |
| 2024-12-16 | Taylor Ben R | Officer | F-InKind | D | Class A Common Stock | 15,668 | 6.04 | 94.6K | 480,924 | D | ↗ |
| 2024-12-05 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 6,016,700 | D | ↗ |
| 2024-12-04 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 6,036,700 | D | ↗ |
| 2024-11-20 | Taylor Ben R | Officer | — | — | Stock Option (Right to Buy) | 92,748 | 0.06 | 5.6K | 0 | D | ↗ |
| 2024-11-20 | Michor Franziska | Director | A-Award | A | Stock Option (Right to Buy) | 15,286 | 7.34 | 112.2K | 15,286 | D | ↗ |
| 2024-11-15 | Secora Michael | Officer | F-InKind | D | Class A Common Stock | 11,937 | 6.18 | 73.7K | 1,487,694 | D | ↗ |
| 2024-11-15 | Mauro David J | Officer | F-InKind | D | Class A Common Stock | 4,187 | 6.18 | 25.9K | 225,429 | D | ↗ |
| 2024-11-15 | Marriott Tina | Officer | F-InKind | D | Class A Common Stock | 14,286 | 6.18 | 88.2K | 506,852 | D | ↗ |
| 2024-11-15 | Gibson Christopher | Director / Officer | F-InKind | D | Class A Common Stock | 26,023 | 6.18 | 160.7K | 736,633 | D | ↗ |
| 2024-11-14 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 6,056,700 | D | ↗ |
| 2024-11-13 | Secora Michael | Officer | M-Exempt | D | Stock Option (Right to Buy) | 39,375 | 2.22 | 87.4K | 337,635 | D | ↗ |
| 2024-11-13 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 6,076,700 | D | ↗ |
| 2024-11-12 | Secora Michael | Officer | M-Exempt | A | Class A Common Stock | 39,375 | 2.22 | 87.4K | 1,490,256 | D | ↗ |
| 2024-11-12 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 7.64 | 87.5K | 7,066,113 | D | ↗ |
| 2024-10-29 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 6.72 | 76.9K | 7,077,560 | D | ↗ |
| 2024-10-24 | Marriott Tina | Officer | M-Exempt | A | Class A Common Stock | 6,000 | 1.06 | 6.4K | 527,138 | D | ↗ |
| 2024-10-15 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 6.67 | 76.3K | 7,089,007 | D | ↗ |
| 2024-10-09 | Secora Michael | Officer | M-Exempt | A | Class A Common Stock | 39,375 | 2.22 | 87.4K | 1,465,881 | D | ↗ |
| 2024-10-08 | Secora Michael | Officer | S-Sale | D | Class A Common Stock | 15,000 | 6.32 | 94.8K | 1,426,506 | D | ↗ |
| 2024-10-03 | Gibson Christopher | Director / Officer | C-Conversion | A | Class A Common Stock | 20,000 | 0.00 | — | 782,656 | D | ↗ |
| 2024-10-02 | Gibson Christopher | Director / Officer | S-Sale | D | Class A Common Stock | 20,000 | 6.16 | 123.2K | 762,656 | D | ↗ |
| 2024-10-01 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 1,925 | 0.00 | — | 75,703 | D | ↗ |
| 2024-10-01 | Dar Zavain | Director | A-Award | A | Class A Common Stock | 2,229 | 0.00 | — | 106,225 | D | ↗ |
| 2024-10-01 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 6.22 | 71.1K | 7,098,428 | D | ↗ |
| 2024-09-26 | Marriott Tina | Officer | M-Exempt | A | Class A Common Stock | 6,000 | 1.06 | 6.4K | 527,138 | D | ↗ |
| 2024-09-17 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 6.84 | 78.3K | 7,109,875 | — | ↗ |
| 2024-09-11 | Secora Michael | Officer | S-Sale | D | Class A Common Stock | 15,000 | 6.32 | 94.7K | 1,402,131 | — | ↗ |
| 2024-09-10 | Secora Michael | Officer | M-Exempt | D | Stock Option (Right to Buy) | 39,375 | 2.22 | 87.4K | 534,510 | — | ↗ |
| 2024-09-05 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 6,136,700 | — | ↗ |
| 2024-09-04 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 6,156,700 | — | ↗ |
| 2024-09-03 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 6.27 | 71.7K | 7,121,322 | — | ↗ |
| 2024-08-30 | Gibson Christopher | Director / Officer | M-Exempt | A | Class A Common Stock | 5,000 | 2.48 | 12.4K | 762,656 | — | ↗ |
| 2024-08-29 | Marriott Tina | Officer | M-Exempt | D | Stock Option (Right to Buy) | 6,000 | 1.06 | 6.4K | 464,000 | — | ↗ |
| 2024-08-29 | Gibson Christopher | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 5,000 | 2.48 | 12.4K | 287,500 | — | ↗ |
| 2024-08-28 | Gibson Christopher | Director / Officer | M-Exempt | A | Class A Common Stock | 5,000 | 2.48 | 12.4K | 752,656 | — | ↗ |
| 2024-08-27 | Gibson Christopher | Director / Officer | M-Exempt | A | Class A Common Stock | 5,000 | 2.48 | 12.4K | 747,656 | — | ↗ |
| 2024-08-26 | Gibson Christopher | Director / Officer | M-Exempt | A | Class A Common Stock | 5,000 | 2.48 | 12.4K | 742,656 | — | ↗ |
| 2024-08-23 | Gibson Christopher | Director / Officer | M-Exempt | A | Class A Common Stock | 5,000 | 2.48 | 12.4K | 737,656 | — | ↗ |
| 2024-08-20 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 7.12 | 81.5K | 7,132,769 | — | ↗ |
| 2024-08-15 | Secora Michael | Officer | F-InKind | D | Class A Common Stock | 11,962 | 6.69 | 80.0K | 1,353,381 | — | ↗ |
| 2024-08-15 | Mauro David J | Officer | F-InKind | D | Class A Common Stock | 14,146 | 6.69 | 94.6K | 229,616 | — | ↗ |
| 2024-08-15 | Marriott Tina | Officer | F-InKind | D | Class A Common Stock | 14,319 | 6.69 | 95.8K | 521,138 | — | ↗ |
| 2024-08-15 | Gibson Christopher | Director / Officer | F-InKind | D | Class A Common Stock | 26,082 | 6.69 | 174.5K | 732,656 | — | ↗ |
| 2024-08-14 | Secora Michael | Officer | M-Exempt | D | Stock Option (Right to Buy) | 39,375 | 2.22 | 87.4K | 573,885 | — | ↗ |
| 2024-08-13 | Secora Michael | Officer | S-Sale | D | Class A Common Stock | 15,000 | 6.35 | 95.2K | 1,340,968 | — | ↗ |
| 2024-08-08 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 20,000 | 0.00 | — | 6,176,700 | — | ↗ |
| 2024-08-07 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 30,000 | 0.00 | — | 6,196,700 | — | ↗ |
| 2024-08-06 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 6.82 | 78.1K | 7,144,216 | — | ↗ |
| 2024-08-01 | Khan Najat | Director / Officer | A-Award | A | Class A Common Stock | 496,972 | 0.00 | — | 496,972 | — | ↗ |
| 2024-07-25 | Marriott Tina | Officer | S-Sale | D | Class A Common Stock | 6,000 | 8.13 | 48.8K | 535,457 | — | ↗ |
| 2024-07-23 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 8.48 | 97.0K | 7,155,663 | — | ↗ |
| 2024-07-11 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 50,000 | 0.00 | — | 6,226,700 | — | ↗ |
| 2024-07-10 | Secora Michael | Officer | M-Exempt | D | Stock Option (Right to Buy) | 39,375 | 2.22 | 87.4K | 652,635 | — | ↗ |
| 2024-07-10 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 50,000 | 0.00 | — | 6,276,700 | — | ↗ |
| 2024-07-09 | Secora Michael | Officer | S-Sale | D | Class A Common Stock | 15,000 | 7.32 | 109.8K | 1,292,218 | — | ↗ |
| 2024-07-09 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 7.32 | 83.7K | 7,167,110 | — | ↗ |
| 2024-07-01 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 1,592 | 0.00 | — | 73,778 | — | ↗ |
| 2024-07-01 | Dar Zavain | Director | A-Award | A | Class A Common Stock | 1,843 | 0.00 | — | 103,996 | — | ↗ |
| 2024-07-01 | Burrell Terry-Ann | Director | A-Award | A | Class A Common Stock | 1,843 | 0.00 | — | 71,254 | — | ↗ |
| 2024-07-01 | Borgeson Blake | Director | A-Award | A | Class A Common Stock | 1,441 | 0.00 | — | 7,178,557 | — | ↗ |
| 2024-06-27 | Marriott Tina | Officer | M-Exempt | A | Class A Common Stock | 6,000 | 1.06 | 6.4K | 541,457 | — | ↗ |
| 2024-06-25 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 9.51 | 108.8K | 7,177,116 | — | ↗ |
| 2024-06-14 | Secora Michael | Officer | M-Exempt | A | Class A Common Stock | 39,375 | 2.22 | 87.4K | 1,282,843 | — | ↗ |
| 2024-06-13 | Secora Michael | Officer | S-Sale | D | Class A Common Stock | 15,000 | 9.32 | 139.8K | 1,243,468 | — | ↗ |
| 2024-06-11 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 8.45 | 96.8K | 7,188,563 | — | ↗ |
| 2024-06-06 | Gibson Christopher | Director / Officer | S-Sale | D | Class A Common Stock | 50,000 | 9.00 | 450.0K | 708,738 | — | ↗ |
| 2024-06-05 | Gibson Christopher | Director / Officer | C-Conversion | A | Class A Common Stock | 25,000 | 0.00 | — | 833,738 | — | ↗ |
| 2024-06-03 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 13,097 | 0.00 | — | 72,186 | — | ↗ |
| 2024-06-03 | HERSHBERG ROBERT | Director | A-Award | A | Class A Common Stock | 13,097 | 0.00 | — | 51,716 | — | ↗ |
| 2024-06-03 | Dar Zavain | Director | A-Award | A | Stock Option (Right to Buy) | 26,193 | 8.59 | 225.0K | 26,193 | — | ↗ |
| 2024-06-03 | Burrell Terry-Ann | Director | A-Award | A | Class A Common Stock | 13,097 | 0.00 | — | 69,411 | — | ↗ |
| 2024-06-03 | Borgeson Blake | Director | A-Award | A | Stock Option (Right to Buy) | 26,193 | 8.59 | 225.0K | 26,193 | — | ↗ |
| 2024-05-30 | Marriott Tina | Officer | M-Exempt | A | Class A Common Stock | 3,000 | 1.06 | 3.2K | 538,457 | — | ↗ |
| 2024-05-28 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 9.17 | 104.9K | 7,186,913 | — | ↗ |
| 2024-05-15 | Secora Michael | Officer | F-InKind | D | Class A Common Stock | 11,962 | 10.01 | 119.7K | 1,219,093 | — | ↗ |
| 2024-05-15 | Mauro David J | Officer | F-InKind | D | Class A Common Stock | 867 | 10.01 | 8.7K | 243,762 | — | ↗ |
| 2024-05-15 | Marriott Tina | Officer | F-InKind | D | Class A Common Stock | 9,998 | 10.01 | 100.1K | 533,233 | — | ↗ |
| 2024-05-15 | Gibson Christopher | Director / Officer | F-InKind | D | Class A Common Stock | 26,082 | 10.01 | 261.1K | 808,738 | — | ↗ |
| 2024-05-14 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 20,054 | 10.12 | 202.9K | 7,198,360 | — | ↗ |
| 2024-05-02 | Gibson Christopher | Director / Officer | C-Conversion | D | Class B Common Stock | 21,296 | 0.00 | — | 6,426,700 | — | ↗ |
| 2024-05-01 | Gibson Christopher | Director / Officer | G-Gift | D | Class A Common Stock | 25,000 | 0.00 | — | 913,524 | — | ↗ |
| 2024-04-30 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 7.95 | 91.0K | 7,218,414 | — | ↗ |
| 2024-04-25 | Marriott Tina | Officer | S-Sale | D | Class A Common Stock | 3,000 | 7.67 | 23.0K | 543,231 | — | ↗ |
| 2024-04-17 | Secora Michael | Officer | M-Exempt | A | Class A Common Stock | 37,500 | 2.22 | 83.3K | 1,254,179 | — | ↗ |
| 2024-04-16 | Secora Michael | Officer | M-Exempt | A | Class A Common Stock | 37,500 | 2.22 | 83.3K | 1,241,679 | — | ↗ |
| 2024-04-16 | Khan Najat | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-04-16 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 7.66 | 87.7K | 7,229,861 | — | ↗ |
| 2024-04-04 | Gibson Christopher | Director / Officer | S-Sale | D | Class A Common Stock | 25,000 | 9.02 | 225.5K | 0 | — | ↗ |
| 2024-04-03 | Gibson Christopher | Director / Officer | G-Gift | D | Class A Common Stock | 25,000 | 0.00 | — | 1,018,524 | — | ↗ |
| 2024-04-02 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 11,447 | 8.82 | 100.9K | 7,241,308 | — | ↗ |
| 2024-04-01 | Li Dean Y | Director | A-Award | A | Class A Common Stock | 1,267 | 0.00 | — | 59,089 | — | ↗ |
| 2024-04-01 | Dar Zavain | Director | A-Award | A | Class A Common Stock | 1,467 | 0.00 | — | 89,056 | — | ↗ |
| 2024-04-01 | CHAVEZ R. MARTIN | Director | A-Award | A | Class A Common Stock | 2,001 | 0.00 | — | 60,078 | — | ↗ |
| 2024-04-01 | Burrell Terry-Ann | Director | A-Award | A | Class A Common Stock | 1,467 | 0.00 | — | 56,314 | — | ↗ |
| 2024-03-28 | Gibson Christopher | Director / Officer | G-Gift | D | Class A Common Stock | 25,000 | 0.00 | — | 1,083,524 | — | ↗ |
| 2024-03-21 | Marriott Tina | Officer | S-Sale | D | Class A Common Stock | 7,390 | 10.70 | 79.1K | 640,592 | — | ↗ |
| 2024-03-19 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 20,054 | 10.79 | 216.4K | 7,252,755 | — | ↗ |
| 2024-03-13 | Secora Michael | Officer | S-Sale | D | Class A Common Stock | 25,000 | 11.03 | 275.8K | 1,204,179 | — | ↗ |
| 2024-03-12 | Secora Michael | Officer | M-Exempt | A | Class A Common Stock | 37,500 | 2.22 | 83.3K | 1,216,679 | — | ↗ |
| 2024-03-06 | Gibson Christopher | Director / Officer | S-Sale | D | Class A Common Stock | 4,000 | 11.56 | 46.3K | 0 | — | ↗ |
| 2024-03-05 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 20,054 | 12.06 | 241.8K | 7,272,809 | — | ↗ |
| 2024-02-22 | Marriott Tina | Officer | M-Exempt | A | Class A Common Stock | 8,000 | 1.06 | 8.5K | 647,982 | — | ↗ |
| 2024-02-20 | Borgeson Blake | Director | S-Sale | D | Class A Common Stock | 19,745 | 12.31 | 243.1K | 7,293,172 | — | ↗ |
| 2024-02-15 | Secora Michael | Officer | F-InKind | D | Class A Common Stock | 7,172 | 12.43 | 89.1K | 1,179,179 | — | ↗ |
| 2024-02-15 | Marriott Tina | Officer | F-InKind | D | Class A Common Stock | 5,379 | 12.43 | 66.9K | 639,982 | — | ↗ |
| 2024-02-15 | Gibson Christopher | Director / Officer | F-InKind | D | Class A Common Stock | 11,148 | 12.43 | 138.6K | 1,104,919 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-8.0K
Shares Outstanding
447.19M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Christopher Gibson, former Chief Executive Officer and President and current Chair of the Board | 680.0K | — | 3.81M | 4.85M | 256.8K | 15.7K | 9.61M | 90.09% | ↗ |
| 2 | 2025 | Najat Khan, current Chief Executive Officer and President | 600.0K | — | 1.94M | 2.50M | 256.8K | 46.7K | 5.35M | 83.11% | ↗ |
| 3 | 2025 | Ben Taylor, Chief Financial Officer | 538.7K | — | 253.9K | 323.1K | 205.2K | 7.6K | 1.33M | 43.43% | ↗ |
| 4 | 2024 | Najat Khan, Chief R&D and Chief Commercial Officer | 285.0K | 500.0K | 3.65M | 4.59M | 115.8K | 54.2K | 9.19M | 89.61% | ↗ |
| 5 | 2024 | Najat Khan, current Chief Executive Officer and President | 285.0K | 500.0K | 3.65M | 4.59M | 115.8K | 54.2K | 9.19M | 89.61% | ↗ |
| 6 | 2024 | Christopher Gibson, former Chief Executive Officer and President and current Chair of the Board | 600.0K | — | 3.36M | 4.27M | 241.9K | 18.4K | 8.50M | 89.88% | ↗ |
| 7 | 2024 | Christopher Gibson, Chief Executive Officer | 600.0K | — | 3.36M | 4.27M | 241.9K | 18.4K | 8.50M | 89.88% | ↗ |
| 8 | 2024 | Ben Taylor, Chief Financial Officer | 53.4K | — | 2.26M | 5.66M | 200.3K | — | 8.17M | 96.90% | ↗ |
| 9 | 2024 | Tina Marriott, Former Chief Operating Officer and President | 530.0K | — | 2.26M | 2.87M | 213.6K | 19.1K | 5.89M | 87.06% | ↗ |
| 10 | 2024 | Michael Secora, Former Chief Financial Officer | 475.0K | — | 1.76M | 2.23M | — | 577.8K | 5.04M | 79.13% | ↗ |
| 11 | 2024 | David Mauro, Chief Medical Officer | 525.0K | — | 502.2K | 638.0K | 211.6K | 56.8K | 1.93M | 58.97% | ↗ |
| 12 | 2023 | Christopher Gibson, Chief Executive Officer | 560.8K | — | 3.48M | 4.33M | 224.5K | 21.4K | 8.61M | 90.63% | ↗ |
| 13 | 2023 | Christopher Gibson, former Chief Executive Officer and President and current Chair of the Board | 560.8K | — | 3.48M | 4.33M | 224.5K | 21.4K | 8.61M | 90.63% | ↗ |
| 14 | 2023 | Tina Marriott, Chief Operating Officer and President | 485.7K | — | 1.86M | 2.31M | 194.4K | 22.1K | 4.87M | 85.57% | ↗ |
| 15 | 2023 | Tina Marriott, Former Chief Operating Officer and President | 485.7K | — | 1.86M | 2.31M | 194.4K | 22.1K | 4.87M | 85.57% | ↗ |
| 16 | 2023 | Michael Secora, Former Chief Financial Officer | 435.6K | — | 1.73M | 2.15M | 174.4K | 19.8K | 4.51M | 86.05% | ↗ |
| 17 | 2023 | Michael Secora, Chief Financial Officer | 435.6K | — | 1.73M | 2.15M | 174.4K | 19.8K | 4.51M | 86.05% | ↗ |
| 18 | 2023 | David Mauro, Chief Medical Officer | 303.3K | — | 1.67M | 2.18M | 121.6K | 33.2K | 4.31M | 89.38% | ↗ |
| 19 | 2023 | Shafique Virani, Former Chief Corporate Development Officer | 520.4K | — | 908.5K | 1.13M | 208.4K | 36.2K | 2.80M | 72.72% | ↗ |
| 20 | 2022 | Christopher Gibson, Chief Executive Officer | 497.5K | — | 2.57M | 3.05M | 185.5K | 12.2K | 6.32M | 88.99% | ↗ |
| 21 | 2022 | Christopher Gibson, Chief Executive Officer Tina Marriott Larson, Chief Operating Officer and President | 497.5K | — | 2.57M | 3.05M | 185.5K | 12.2K | 6.30M | 89.17% | ↗ |
| 22 | 2022 | Tina Marriott, Chief Operating Officer and President | 437.8K | — | 984.0K | 1.17M | 163.3K | 11.6K | 2.76M | 77.82% | ↗ |
| 23 | 2022 | Tina Marriott, Former Chief Operating Officer and President | 437.8K | — | 984.0K | 1.17M | 163.3K | 11.6K | 2.76M | 77.82% | ↗ |
| 24 | 2022 | Tina Marriott Larson, Chief Operating Officer and President Michael Secora, Chief Financial Officer | 437.8K | — | 984.0K | 1.17M | 163.3K | 11.6K | 2.75M | 78.15% | ↗ |
| 25 | 2022 | Michael Secora, Chief Financial Officer | 348.3K | — | 721.1K | 845.1K | 129.8K | 46.1K | 2.09M | 74.92% | ↗ |
| 26 | 2022 | Michael Secora, Former Chief Financial Officer | 348.3K | — | 721.1K | 845.1K | 129.8K | 46.1K | 2.09M | 74.92% | ↗ |
| 27 | 2022 | Michael Secora, Chief Financial Officer Shafique Virani, Chief Corporate Development Office | 348.3K | — | 721.1K | 845.1K | 129.8K | 46.1K | 2.04M | 76.61% | ↗ |
| 28 | 2022 | Shafique Virani, Former Chief Corporate Development Officer | 488.3K | — | 497.2K | 588.9K | 181.9K | 11.6K | 1.77M | 61.43% | ↗ |
| 29 | 2022 | Shafique Virani, Chief Corporate Development Office Ramona Doyle, Chief Medical Officer | 488.3K | — | 497.2K | 588.9K | 181.9K | 11.6K | 1.76M | 61.84% | ↗ |
| 30 | 2022 | Ramona Doyle, Chief Medical Officer | 167.9K | — | 475.8K | 563.6K | — | 359.1K | 1.21M | 86.09% | ↗ |
| 31 | 2021 | Shafique Virani, Former Chief Corporate Development Officer | 500.0K | — | — | — | 175.0K | 13.2K | 688.2K | 0.00% | ↗ |
| 32 | 2021 | Shafique Virani, Chief Corporate Development Office | 500.0K | — | — | — | 175.0K | 13.2K | 688.2K | 0.00% | ↗ |
| 33 | 2021 | Christopher Gibson, Chief Executive Officer | 485.4K | — | — | — | 175.0K | 13.2K | 673.6K | 0.00% | ↗ |
| 34 | 2021 | Christopher Gibson, Chief Executive Officer Ramona Doyle, Chief Medical Officer | 485.4K | — | — | — | 175.0K | 13.2K | 673.6K | 0.00% | ↗ |
| 35 | 2021 | Ramona Doyle, Chief Medical Officer | 440.3K | — | — | — | 154.0K | 13.2K | 607.5K | 0.00% | ↗ |
| 36 | 2021 | Ramona Doyle, Chief Medical Officer Tina Marriott Larson, Chief Operating Officer and President | 440.3K | — | — | — | 154.0K | 13.2K | 607.5K | 0.00% | ↗ |
| 37 | 2021 | Tina Marriott Larson, Chief Operating Officer and President Michael Secora, Chief Financial Officer | 428.8K | — | — | — | 154.0K | 13.2K | 595.9K | 0.00% | ↗ |
| 38 | 2021 | Tina Marriott Larson, Chief Operating Officer and President | 428.8K | — | — | — | 154.0K | 13.2K | 595.9K | 0.00% | ↗ |
| 39 | 2021 | Tina Marriott, Chief Operating Officer and President | 428.8K | — | — | — | 154.0K | 13.2K | 595.9K | 0.00% | ↗ |
| 40 | 2021 | Michael Secora, Chief Financial Officer Shafique Virani, Chief Corporate Development Office | 307.7K | 63.5K | — | — | 126.0K | 13.2K | 510.3K | 0.00% | ↗ |
| 41 | 2021 | Michael Secora, Chief Financial Officer | 307.7K | 63.5K | — | — | 126.0K | 13.2K | 510.3K | 0.00% | ↗ |
| 42 | 2020 | Tina Marriott Larson, Chief Operating Officer and President Michael Secora, Chief Financial Officer | 170.8K | 63.0K | — | 3.43M | 15.4K | 37.5K | 3.72M | 92.29% | ↗ |
| 43 | 2020 | Christopher Gibson, Chief Executive Officer | 269.6K | 13.0K | — | 2.27M | 20.4K | 12.7K | 2.58M | 87.78% | ↗ |
| 44 | 2020 | Michael Secora, Chief Financial Officer Shafique Virani, Chief Corporate Development Office | 413.5K | 13.0K | — | 991.7K | 28.2K | 20.5K | 1.47M | 67.61% | ↗ |
| 45 | 2020 | Shafique Virani, Chief Corporate Development Office Ramona Doyle, Chief Medical Officer | 3.7K | — | — | 1.13M | — | — | 1.14M | 99.68% | ↗ |
| 46 | 2020 | Christopher Gibson, Chief Executive Officer Ramona Doyle, Chief Medical Officer | 3.7K | — | — | 1.13M | — | — | 1.14M | 99.68% | ↗ |
| 47 | 2020 | Ramona Doyle, Chief Medical Officer Tina Marriott Larson, Chief Operating Officer and President | 408.2K | 13.0K | — | 226.9K | 30.1K | 12.7K | 690.8K | 32.84% | ↗ |
| 48 | 2020 | Christopher Gibson, Chief Executive Officer Tina Marriott Larson, Chief Operating Officer and President | 408.2K | 13.0K | — | 226.9K | 30.1K | 12.7K | 690.8K | 32.84% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Najat Khan | CEO, President & Director | 955.0K | — |
| Christopher C. Gibson | Co-Founder, Chairman & Interim Executive Advisor | 860.3K | — |
| David J. Mauro | Advisor | 793.4K | — |
| Ben R. Taylor | Chief Financial Officer & President of Recursion UK | 669.1K | male |
| Erica Fox | Chief People and Impact Officer | — | female |
| Kristen Rushton | Chief Operating Officer | — | female |
| Matthew Kinn | Chief Business Officer | — | male |
| Nathan Hatfield | Chief Legal Officer & Corporate Secretary | — | male |
| Ryan Kelly | Chief Communications Officer | — | male |
| Benjamin Mabey | Chief Technology Officer | — | male |
| David Hallett | Chief Scientific Officer | — | — |
| Elizabeth Bruckheimer | Vice President of Clinical Development | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RXRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
